Joel Schmitz Selected Research

Joel Schmitz Research Topics

2	Obesity 12/2017 - 05/2014
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Hypertriglyceridemia 01/2018
1	Pancreatitis 01/2018
1	Type 2 Diabetes Mellitus (MODY) 12/2017
1	Anhidrotic Ectodermal Dysplasia 1 12/2017
1	Insulin Resistance 12/2017
1	Hypercholesterolemia 01/2017
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Inflammation (Inflammations) 05/2014
1	Endotoxemia 05/2014
1	Ischemia 07/2008
1	Hypoxia (Hypoxemia) 07/2008
1	Reperfusion Injury 07/2008
1	Myocardial Infarction 07/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 07/2008

2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 12/2017 - 05/2014
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	ISIS 304801IBA 01/2018
1	Fibric Acids (Fibrates)IBA 01/2018
1	Apolipoprotein C-IIIIBA 01/2018
1	Antisense OligonucleotidesIBA 01/2018
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2018
1	EctodysplasinsIBA 12/2017
1	Proteins (Proteins, Gene)FDA Link 12/2017
1	Serine (L-Serine)FDA Link 12/2017
1	MicroRNAs (MicroRNA)IBA 12/2017
1	oxidized low density lipoproteinIBA 01/2017
1	alirocumabIBA 01/2017
1	evolocumabIBA 01/2017
1	AntibodiesIBA 01/2017
1	LipopolysaccharidesIBA 05/2014
1	Insulin (Novolin)FDA Link 05/2014
1	Interleukin-6 (Interleukin 6)IBA 05/2014
1	Hemoglobins (Hemoglobin)IBA 07/2008
1	Nitrite Reductases (Nitrite Reductase)IBA 07/2008
1	NitritesIBA 07/2008
1	MyoglobinIBA 07/2008

1	Therapeutics 01/2017